These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30100328)

  • 1. Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer.
    Pavithra D; Sabitha K; Rajkumar T
    Comput Biol Chem; 2018 Dec; 77():442-454. PubMed ID: 30100328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
    Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
    ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive identification of potential molecular targets and small drugs candidate for melanoma cancer using bioinformatics and network-based screening approach.
    Khan DA; Adhikary T; Sultana MT; Toukir IA
    J Biomol Struct Dyn; 2024 Sep; 42(14):7349-7369. PubMed ID: 37534476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.
    Di Giorgio A; Tran TP; Duca M
    Future Med Chem; 2016 May; 8(7):803-16. PubMed ID: 27149207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Gastric Cancer-Related Circular RNA through Microarray Analysis and Bioinformatics Analysis.
    Gu W; Sun Y; Zheng X; Ma J; Hu XY; Gao T; Hu MJ
    Biomed Res Int; 2018; 2018():2381680. PubMed ID: 29744354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.
    Shrestha S; Yang CD; Hong HC; Chou CH; Tai CS; Chiew MY; Chen WL; Weng SL; Chen CC; Chang YA; Lee ML; Huang WY; Hsu SD; Chen YC; Huang HD
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of the miRNA, gene and pathway regulatory network in gastric cancer.
    Zhang H; Qu Y; Duan J; Deng T; Liu R; Zhang L; Bai M; Li J; Zhou L; Ning T; Li H; Ge S; Li H; Ying G; Huang D; Ba Y
    Oncol Rep; 2016 Feb; 35(2):1135-46. PubMed ID: 26719093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Small Molecule Modulators of MicroRNA by Library Screening.
    Xiao Z; Chen Y
    Methods Mol Biol; 2017; 1517():169-178. PubMed ID: 27924482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation analysis reveals dysfunctional regulatory mechanism involving transcription factors and microRNAs in gastric carcinogenesis.
    Li Q; Li J; Dai W; Li YX; Li YY
    Artif Intell Med; 2017 Mar; 77():12-22. PubMed ID: 28545608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB7 and Hsa-miR-222 as the Potential Therapeutic Candidates for Metastatic Colorectal Cancer.
    Iman M; Mostafavi SS; Arab SS; Azimzadeh S; Poorebrahim M
    Recent Pat Anticancer Drug Discov; 2016; 11(4):434-443. PubMed ID: 27855613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target genes prediction and functional analysis of microRNAs differentially expressed in gastric cancer stem cells MKN-45.
    Salehi Z; Akrami H
    J Cancer Res Ther; 2017; 13(3):477-483. PubMed ID: 28862212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy.
    Jurj A; Fontana B; Varani G; Calin GA
    Trends Cancer; 2024 Sep; 10(9):809-824. PubMed ID: 39107162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of gastric cancer.
    Jiang HB; Yang TJ; Lu P; Ma YJ
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2109-15. PubMed ID: 25070814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of associations between small molecule drugs and miRNAs based on functional similarity.
    Wang J; Meng F; Dai E; Yang F; Wang S; Chen X; Yang L; Wang Y; Jiang W
    Oncotarget; 2016 Jun; 7(25):38658-38669. PubMed ID: 27232942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
    Li X; Luo F; Li Q; Xu M; Feng D; Zhang G; Wu W
    Oncol Rep; 2011 Dec; 26(6):1431-9. PubMed ID: 21874264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.
    Zhang X; Peng Y; Jin Z; Huang W; Cheng Y; Liu Y; Feng X; Yang M; Huang Y; Zhao Z; Wang L; Wei Y; Fan X; Zheng D; Meltzer SJ
    Oncotarget; 2015 Oct; 6(32):32878-89. PubMed ID: 26460735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis.
    Huang J; Wen F; Huang W; Bai Y; Lu X; Shu P
    Biomark Med; 2020 Aug; 14(12):1069-1084. PubMed ID: 32969243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.